Peiminine regulates the biological characteristics of colorectal cancer cells via P13K/Akt/mTOR and oxidative stress pathways
Purpose: To investigate the influence of peiminine on biological characteristics of colorectal cancer cells, and the underlying mechanism.
Methods: Two groups of cultured human colorectal cancer HCT-116 cells were used: peiminine and control groups. Peiminine group cells were exposed to the drug at a final concentration of 100 μmol/L. The effect of peiminine on cell proliferation was determined with CCK-8 method, while its effect on apoptosis was determined with flow cytometric method. Cell migration was determined with scratch test. The effect of peiminine on the expressions of proteins associated with the P13K/Akt/mTOR pathway and Wnt/β-catenin pathway in HCT-116 cells was determined with Western blotting assay.
Results: Cell proliferation was markedly reduced in the peiminine group, relative to control (p < 0.05). There was higher percentage cell apoptosis in peiminine-treated cells than in control. Moreover, cell migration potential was significantly lower in the peiminine-treated cells. There were significantly downregulated levels of p-P13K, p-Akt and p-mTOR expressions in peiminine group, relative to the corresponding control expressions (p < 0.05). However, there were significantly higher relative expression of Wnt in peiminine group than in control cells, but β-catenin level was reduced, relative to the corresponding control level (p < 0.05).
Conclusion: These data indicate that peiminine suppresses the proliferative, apoptotic and migratory potential of colorectal carcinoma HCT-116 cells via regulation of P13K/Akt/mTOR and oxidative stress pathways.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.